Increase/Decrease in Cash: The total change in cash for the company over the given period.
Pfizer Inc. (PFE) had Increase/Decrease in Cash of $91.00M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$17.56B |
|
$-1.65B |
|
$5.27B |
|
$12.29B |
|
$14.69B |
|
$2.87B |
|
$-4.51B |
|
$-1.64B |
|
$-1.64B |
|
$-1.64B |
|
$-1.64B |
|
$-1.64B |
|
$-1.64B |
|
$2.87B |
|
$4.56B |
|
5.68B |
|
5.71B |
|
$-0.28 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$42.90B |
|
$19.32B |
|
$165.26B |
|
$208.16B |
|
$36.98B |
|
$61.64B |
|
$84.40B |
|
$121.39B |
|
$86.78B |
|
$-38.22B |
|
$86.78B |
|
5.69B |
|
| Cash Flow Statement Financials | |
$11.70B |
|
$-1.35B |
|
$-10.30B |
|
$1.11B |
|
$1.20B |
|
|
Increase/Decrease in Cash |
$91.00M |
$799.00M |
|
$-9.77B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.16 |
|
-- |
|
-- |
|
0.42 |
|
0.75 |
|
69.97% |
|
16.36% |
|
16.36% |
|
-- |
|
-9.36% |
|
-9.38% |
|
$9.07B |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.49 |
|
1.48 |
|
60.87 |
|
-1.89% |
|
4.29% |
|
-0.79% |
|
-1.10% |
|
$15.26 |
|
$1.59 |
|
$2.05 |
|